share_log

HC Wainwright & Co. Reiterates Buy on Evaxion Biotech, Maintains $14 Price Target

Moomoo 24/7 ·  Apr 3 06:41

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment